"FREM2 is thus proposed as a novel GB biomarker and a putative biomarker of glioblastoma stem cells. Both FREM2 and SPRY1 are expressed on the surface of the GB cells while SPRY1 alone was found overexpressed in the cytosol of non-malignant astrocytes."xsd:string